BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Amunix, Inc. 

500 Ellis Street
Suite B
Mountain View  California  94043  U.S.A.
Phone: 650-428-1800 Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Biotechnology





 Company News
Amunix, Inc. Announces Option Exercise By Eli Lilly (LLY) For XTEN™ Product For People With Diabetes 12/18/2014 11:25:31 AM
Amunix, Inc. And PolyPeptide Laboratories Inc. Enter Into Partnership To Produce XTEN™ Peptide Conjugates For Evaluation By Third Parties For Pharmaceutical Therapeutics 10/28/2014 10:40:53 AM
Amunix, Inc. Signs A Services And Supply Agreement With The University Of Nebraska-Lincoln To Produce GMP-Grade XTEN™ For Pharmaceutical Therapeutics 10/27/2014 11:12:28 AM
Amunix, Inc. And PolyPeptide Publish Multivalent Antiviral XTEN-Peptide Conjugates In Vivo Studies In American Chemical Society's Journal 7/24/2014 1:11:10 PM
Amunix, Inc. Congratulates Versartis, Inc. (VSAR) On Its Positive Phase 2a Results With VRS-317 6/30/2014 11:13:03 AM
Amunix, Inc. Presents XTEN Half-Life Extension Technology At Next Generation Protein Therapeutics Summit 6/6/2014 8:44:39 AM
Amunix, Inc. To Present Unpublished Data At Next Generation Protein Therapeutics Summit 5/28/2014 11:22:42 AM
Biogen Idec, Inc. (California) (BIIB) Signs License Agreement With Amunix, Inc. For XTENylated Factor VIII 4/21/2014 10:03:52 AM
Amunix, Inc. Announces Expansion To Licensing Agreement With Janssen Biotech Inc. (JNJ) For Its Proprietary XTEN Technology 1/7/2014 9:44:17 AM
Amunix, Inc. Announces Update to Licensing Agreement With Janssen Biotech Inc. for Its Proprietary XTEN Technology 8/14/2013 9:37:58 AM
12